BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poultsides GA, Huang LC, Cameron JL, Tuli R, Lan L, Hruban RH, Pawlik TM, Herman JM, Edil BH, Ahuja N. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012;19:1928-1935. [PMID: 22167476 DOI: 10.1245/s10434-011-2168-3] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Minatsuki C, Yamamichi N, Inada K, Takahashi Y, Sakurai K, Shimamoto T, Tsuji Y, Shiogama K, Kodashima S, Sakaguchi Y, Niimi K, Ono S, Niwa T, Ohata K, Matsuhashi N, Ichinose M, Fujishiro M, Tsutsumi Y, Koike K. Expression of Gastric Markers Is Associated with Malignant Potential of Nonampullary Duodenal Adenocarcinoma. Dig Dis Sci 2018;63:2617-25. [DOI: 10.1007/s10620-018-5179-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
2 Li D, Si X, Wan T, Zhou Y. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review. Asian J Surg 2019;42:46-52. [PMID: 29802028 DOI: 10.1016/j.asjsur.2018.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Cloyd JM, Norton JA, Visser BC, Poultsides GA. Does the extent of resection impact survival for duodenal adenocarcinoma? Analysis of 1,611 cases. Ann Surg Oncol. 2015;22:573-580. [PMID: 25160736 DOI: 10.1245/s10434-014-4020-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
4 Bahl A, Bhattacharyya T, Kapoor R, Singh OA, Parsee T, Sharma SC. Postoperative radiotherapy in periampullary cancers: a brief review. J Gastrointest Cancer 2013;44:111-4. [PMID: 22843209 DOI: 10.1007/s12029-012-9421-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Khosla D, Dey T, Madan R, Gupta R, Goyal S, Kumar N, Kapoor R. Small bowel adenocarcinoma: An overview. World J Gastrointest Oncol 2022; 14(2): 413-422 [DOI: 10.4251/wjgo.v14.i2.413] [Reference Citation Analysis]
6 Ushiku T, Arnason T, Fukayama M, Lauwers GY. Extra-ampullary duodenal adenocarcinoma. Am J Surg Pathol. 2014;38:1484-1493. [PMID: 25310836 DOI: 10.1097/pas.0000000000000278] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 4.9] [Reference Citation Analysis]
7 Kato Y, Takahashi S, Kinoshita T, Shibasaki H, Gotohda N, Konishi M. Surgical Procedure Depending on the Depth of Tumor Invasion in the Duodenal Cancer. Japanese Journal of Clinical Oncology 2014;44:224-31. [DOI: 10.1093/jjco/hyt213] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
8 Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection. Clinical Colorectal Cancer 2017;16:220-7. [DOI: 10.1016/j.clcc.2016.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
9 Ito R, Mise Y, Takahashi Y, Inoue Y, Kawano F, Tanaka H, Irie S, Ichida H, Yoshioka R, Saiura A. Segmental resection with partial mesopancreatic and mesojejunal excision (pMME) for duodenal carcinoma of the third or fourth portion. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02569-7] [Reference Citation Analysis]
10 Augustin T, Moslim MA, Cengiz TB, El-Hayek K, Simon R, Bhatt A, Tang A, Burke CA, Matthew Walsh R. Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer. J Surg Oncol 2020;122:1132-44. [PMID: 33124067 DOI: 10.1002/jso.26131] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Schwameis K, Schoppmann SF, Stift J, Schwameis M, Stift A. Small bowel adenocarcinoma - terra incognita: A demand for cross-national pooling of data. Oncol Lett 2014;7:1613-7. [PMID: 24765188 DOI: 10.3892/ol.2014.1919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
12 Nitta N, Ohgi K, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ashida R, Sasaki K, Uesaka K. Prognostic Impact of Pancreatic Invasion in Duodenal Carcinoma: A Single-Center Experience. Ann Surg Oncol 2020;27:4553-60. [PMID: 32367502 DOI: 10.1245/s10434-020-08512-8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Cloyd JM, George E, Visser BC. Duodenal adenocarcinoma: Advances in diagnosis and surgical management. World J Gastrointest Surg 2016; 8(3): 212-221 [PMID: 27022448 DOI: 10.4240/wjgs.v8.i3.212] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 27] [Article Influence: 5.7] [Reference Citation Analysis]
14 Chen ZH, Qiu MZ, Wu XY, Wu QN, Lu JH, Zeng ZL, Wang Y, Wei XL, Wang F, Xu RH. Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients. J Cancer 2018;9:512-20. [PMID: 29483956 DOI: 10.7150/jca.22305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Platoff RM, Kellish AS, Hakim A, Gaughan JP, Atabek UM, Spitz FR, Hong YK. Simple Versus Radical Resection for Duodenal Adenocarcinoma: A Propensity Score Matched Analysis of National Cancer Database. Am Surg 2021;87:266-75. [PMID: 32927979 DOI: 10.1177/0003134820951432] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Suh CH, Tirumani SH, Shinagare AB, Kim KW, Rosenthal MH, Ramaiya NH, Baheti AD. Diagnosis and management of duodenal adenocarcinomas: a comprehensive review for the radiologist. Abdom Imaging 2015;40:1110-20. [DOI: 10.1007/s00261-014-0309-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
17 Li BS, Shi H, Wen M, Xiao MY, Wang J. Widespread lymph node recurrence of major duodenal papilla cancer following pancreaticoduodenectomy. World J Gastroenterol 2015; 21(48): 13593-13598 [PMID: 26730173 DOI: 10.3748/wjg.v21.i48.13593] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Hu X, Aivazian K, McKenzie C, Wong M, Kaffes A, Saxena P. A Rare Case of Duodenal Adenocarcinoma Presenting as a Subepithelial Lesion in a Patient Undergoing Investigation for Iron Deficiency Anaemia. Case Rep Gastrointest Med 2019;2019:3434620. [PMID: 31687224 DOI: 10.1155/2019/3434620] [Reference Citation Analysis]
19 Zhang S, Yuan W, Zhang J, Chen Y, Zheng C, Ma J, Jiang Q, Zhao Y, Xu Q, Wang C. Clinicopathological features, surgical treatments, and survival outcomes of patients with small bowel adenocarcinoma. Medicine (Baltimore) 2017;96:e7713. [PMID: 28767610 DOI: 10.1097/MD.0000000000007713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Linden K, Melillo A, Gaughan J, Obinero C, Kellish A, Wozniak MR, Patel RM, Pandya V, Atabek U, Spitz F, Hong YK. The Role of Neoadjuvant Versus Adjuvant Therapy for Duodenal Adenocarcinoma: A National Cancer Database Propensity Score Matched Analysis. Am Surg 2021;87:1066-73. [PMID: 33291951 DOI: 10.1177/0003134820954821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Sakaguchi T, Satoi S, Hashimoto D, Yamamoto T, Yamaki S, Hirooka S, Ishida M, Ikeura T, Inoue K, Naganuma M, Ishikawa H, Sekimoto M. High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma. Surg Today 2022. [PMID: 34988677 DOI: 10.1007/s00595-021-02433-z] [Reference Citation Analysis]
22 Nortunen M, Parkkila S, Saarnio J, Huhta H, Karttunen TJ. Carbonic Anhydrases II and IX in Non-ampullary Duodenal Adenomas and Adenocarcinoma. J Histochem Cytochem 2021;69:677-90. [PMID: 34636283 DOI: 10.1369/00221554211050133] [Reference Citation Analysis]
23 Abe N, Takeuchi H, Hashimoto Y, Yoshimoto E, Kojima Y, Ohki A, Nagao G, Suzuki Y, Horiai S, Mizuno H, Masaki T, Mori T, Sugiyama M. Laparoscopy-assisted transduodenal excision of superficial non-ampullary duodenal epithelial tumors: Laparoscopic transduodenal excision. Asian J Endosc Surg 2015;8:310-5. [DOI: 10.1111/ases.12191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
24 Stilidi IS, Nered SN, Nikulin MP, Egenov OA, Petrosyan AP, Arkhiri PP. Distal duodenectomy: a new option of surgical treatment for duodenal tumors. Khir Z im N I Pirogova 2019. [DOI: 10.17116/hirurgia20190915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Patel PH, Likos-Corbett M, Doyle J, Kumar S, Bhogal RH. Node negative duodenal adenocarcinoma is associated with long-term patient survival following pancreaticoduodenal resection. ANZ J Surg 2022. [PMID: 35403794 DOI: 10.1111/ans.17694] [Reference Citation Analysis]
26 Wen MY, Wang Y, Meng XY, Xie HP. Endoscopic mucosal resection of duodenal bulb adenocarcinoma with neuroendocrine features: An extremely rare case report. World J Gastroenterol 2015; 21(24): 7608-7612 [PMID: 26140012 DOI: 10.3748/wjg.v21.i24.7608] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Klose J, Lasitschka F, Horsch C, Strowitzki MJ, Bruckner T, Volz C, Schmidt T, Schneider M. Prognostic relevance of programmed death-ligand 1 expression and microsatellite status in small bowel adenocarcinoma. Scand J Gastroenterol 2020;55:321-9. [PMID: 32191146 DOI: 10.1080/00365521.2020.1734073] [Reference Citation Analysis]
28 Wang FS, Gao ZJ, Liu YF. Recent advances in diagnosis and treatment of primary duodenal tumors. Shijie Huaren Xiaohua Zazhi 2014; 22(34): 5221-5227 [DOI: 10.11569/wcjd.v22.i34.5221] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
29 Hoteya S, Kaise M, Iizuka T, Ogawa O, Mitani T, Matsui A, Kikuchi D, Furuhata T, Yamashita S, Yamada A, Kimura R, Nomura K, Kuribayashi Y, Miyata Y, Yahagi N. Delayed bleeding after endoscopic submucosal dissection for non-ampullary superficial duodenal neoplasias might be prevented by prophylactic endoscopic closure: analysis of risk factors. Dig Endosc. 2015;27:323-330. [PMID: 25186455 DOI: 10.1111/den.12377] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
30 Esaki M, Suzuki S, Ikehara H, Kusano C, Gotoda T. Endoscopic diagnosis and treatment of superficial non-ampullary duodenal tumors. World J Gastrointest Endosc 2018; 10(9): 156-164 [PMID: 30283598 DOI: 10.4253/wjge.v10.i9.156] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
31 Ohtsuka M, Miyazaki M. Long-Term Survival After Resection of Periampullary Cancer. In: Beger HG, Warshaw AL, Hruban RH, Büchler MW, Lerch MM, Neoptolemos JP, Shimosegawa T, Whitcomb DC, Groß C, editors. The Pancreas. Chichester: John Wiley & Sons, Ltd; 2018. pp. 1097-106. [DOI: 10.1002/9781119188421.ch146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Baghmar S, Agrawal N, Kumar G, Bihari C, Patidar Y, Kumar S, Chattopadhyay TK, Panda D, Arora A, Pamecha V. Prognostic Factors and the Role of Adjuvant Treatment in Periampullary Carcinoma: a Single-Centre Experience of 95 Patients. J Gastrointest Cancer 2019;50:361-9. [PMID: 29464529 DOI: 10.1007/s12029-018-0058-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
33 Wilhelm A, Galata C, Beutner U, Schmied BM, Warschkow R, Steffen T, Brunner W, Post S, Marti L. Duodenal localization is a negative predictor of survival after small bowel adenocarcinoma resection: A population-based, propensity score-matched analysis. J Surg Oncol 2018;117:397-408. [DOI: 10.1002/jso.24877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
34 Jang B, Park HJ, Kim K, Jang J, Kim SW, Oh D, Chie EK. Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution. World J Surg 2018;42:3294-301. [DOI: 10.1007/s00268-018-4692-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
35 Jiang QL, Huang XH, Chen YT, Zhang JW, Wang CF. Prognostic Factors and Clinical Characteristics of Patients with Primary Duodenal Adenocarcinoma: A Single-Center Experience from China. Biomed Res Int 2016;2016:6491049. [PMID: 28116301 DOI: 10.1155/2016/6491049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
36 Kriger AG, Gorin DS, Panteleev VI, Kaldarov AR. Diagnosis and surgical treatment of duodenal tumors. Khir Z im N I Pirogova 2019. [DOI: 10.17116/hirurgia20190115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 He J, Ahuja N, Makary MA, Cameron JL, Eckhauser FE, Choti MA, Hruban RH, Pawlik TM, Wolfgang CL. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 2014;16:83-90. [PMID: 23472829 DOI: 10.1111/hpb.12078] [Cited by in Crossref: 154] [Cited by in F6Publishing: 140] [Article Influence: 17.1] [Reference Citation Analysis]
38 Mann K, Gilbert T, Cicconi S, Jackson R, Whelan P, Campbell F, Halloran C, Neoptolemos J, Ghaneh P. Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. Langenbecks Arch Surg 2019;404:439-49. [PMID: 30972486 DOI: 10.1007/s00423-019-01779-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
39 Malleo G, Tonsi A, Marchegiani G, Casarotto A, Paiella S, Butturini G, Salvia R, Bassi C. Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma. Langenbecks Arch Surg. 2013;398:287-294. [PMID: 22801737 DOI: 10.1007/s00423-012-0978-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
40 Raghav K, Overman MJ. Small bowel adenocarcinomas--existing evidence and evolving paradigms. Nat Rev Clin Oncol. 2013;10:534-544. [PMID: 23897080 DOI: 10.1038/nrclinonc.2013.132] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
41 Lu J, Hu D, Tang H, Hu X, Shen Y, Li Z, Peng Y, Kamel I. Assessment of tumor heterogeneity: Differentiation of periampullary neoplasms based on CT whole-lesion histogram analysis. Eur J Radiol. 2019;115:1-9. [PMID: 31084752 DOI: 10.1016/j.ejrad.2019.03.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
42 Lim YJ, Kim K. Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database. Int J Clin Oncol 2018;23:473-81. [DOI: 10.1007/s10147-017-1226-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Kang CM, Lee JH, Choi JK, Hwang HK, Chung JU, Lee WJ, Kwon KH. Can we recommend surgical treatment to the octogenarian with periampullary cancer?: National database analysis in South Korea. Eur J Cancer 2021;144:81-90. [PMID: 33341449 DOI: 10.1016/j.ejca.2020.10.039] [Reference Citation Analysis]
44 Bracale U, Pontecorvi E, Silvestri V, Cuccurullo D, D'Ambra M, Lionetti R, Coppola A, Carannante F, Pirozzi F, Peltrini R, Sciuto A, Corcione F. Laparoscopic segmental resection for tumours of the Angle of Treitz: a challenging but feasible surgical option. Results from a retrospective case-series analysis. Updates Surg 2021;73:179-86. [PMID: 33146889 DOI: 10.1007/s13304-020-00910-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Kamarajah SK. Pancreaticoduodenectomy for periampullary tumours: a review article based on Surveillance, End Results and Epidemiology (SEER) database. Clin Transl Oncol. 2018;20:1153-1160. [PMID: 29335829 DOI: 10.1007/s12094-018-1832-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
46 Jabbour SK, Mulvihill D. Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol. 2014;24:85-93. [PMID: 24635865 DOI: 10.1016/j.semradonc.2013.11.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
47 Oyasiji T, Alosi J, Tan W, Wilfong C, Wilkinson N. Duodenal Adenocarcinoma: Profile and Predictors of Survival Outcomes. The American Surgeon 2015;81:1125-33. [DOI: 10.1177/000313481508101124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
48 Ye N, Bao X, Zhao X, Wang B. Signet-ring cell carcinoma of the duodenal bulb presenting with gastrointestinal hemorrhage: a case report and literature review. BMC Gastroenterol 2022;22:226. [PMID: 35534806 DOI: 10.1186/s12876-022-02267-0] [Reference Citation Analysis]
49 Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Hum Pathol. 2013;44:2792-2798. [PMID: 24139211 DOI: 10.1016/j.humpath.2013.07.030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
50 Shibagaki K, Ishimura N, Kinoshita Y. Endoscopic submucosal dissection for duodenal tumors. Ann Transl Med 2017;5:188. [PMID: 28616403 DOI: 10.21037/atm.2017.03.63] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
51 Hoteya S, Yahagi N, Iizuka T, Kikuchi D, Mitani T, Matsui A, Ogawa O, Yamashita S, Furuhata T, Yamada A, Kimura R, Nomura K, Kuribayashi Y, Kaise M. Endoscopic submucosal dissection for nonampullary large superficial adenocarcinoma/adenoma of the duodenum: feasibility and long-term outcomes. Endosc Int Open. 2013;1:2-7. [PMID: 26135505 DOI: 10.1055/s-0033-1359232] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
52 Hoteya S, Furuhata T, Takahito T, Fukuma Y, Suzuki Y, Kikuchi D, Mitani T, Matsui A, Yamashita S, Nomura K, Kuribayashi Y, Iizuka T, Kaise M. Endoscopic Submucosal Dissection and Endoscopic Mucosal Resection for Non-Ampullary Superficial Duodenal Tumor. Digestion. 2017;95:36-42. [PMID: 28052275 DOI: 10.1159/000452363] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
53 Tesarikova J, Skalicky P, Kurfurstova D, Svebisova H, Urban O, Falt P, Zapletalova J, Klos D, Lovecek M. Surgical treatment of duodenal adenocarcinoma: ampullary vs. non-ampullary, short- and long-term outcomes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34012147 DOI: 10.5507/bp.2021.028] [Reference Citation Analysis]
54 Zhu Z, Zhong F. Comparative Analysis of Outcomes and Clinicopathological Characteristics of Duodenal Adenocarcinoma: A SEER Analysis. Cancer Invest 2020;38:543-8. [PMID: 33073637 DOI: 10.1080/07357907.2020.1824260] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Yu H, Song H, Jiang Y. Duodenal Adenocarcinoma Metastatic to the Breast: A Case Report. Medicine (Baltimore) 2016;95:e3088. [PMID: 26986146 DOI: 10.1097/MD.0000000000003088] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Buchbjerg T, Fristrup C, Mortensen MB. The incidence and prognosis of true duodenal carcinomas. Surg Oncol. 2015;24:110-116. [PMID: 25936244 DOI: 10.1016/j.suronc.2015.04.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
57 Meijer LL, Alberga AJ, de Bakker JK, van der Vliet HJ, Le Large TYS, van Grieken NCT, de Vries R, Daams F, Zonderhuis BM, Kazemier G. Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2018;25:2681-2692. [PMID: 29946997 DOI: 10.1245/s10434-018-6567-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
58 Dave A, Wiseman JT, Cloyd JM. Duodenal adenocarcinoma: neoadjuvant and adjuvant therapy strategies. Expert Opinion on Orphan Drugs 2019;7:463-72. [DOI: 10.1080/21678707.2019.1684257] [Reference Citation Analysis]
59 Chen EY, Vaccaro GM. Small Bowel Adenocarcinoma. Clin Colon Rectal Surg 2018;31:267-77. [PMID: 30186048 DOI: 10.1055/s-0038-1660482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
60 Jensen KK, Storkholm JH, Chen I, Burgdorf SK, Hansen CP. Long-term results after resection of primary duodenal adenocarcinoma: A retrospective cohort study. International Journal of Surgery 2022. [DOI: 10.1016/j.ijsu.2022.106599] [Reference Citation Analysis]
61 Sakamoto T, Saiura A, Ono Y, Mise Y, Inoue Y, Ishizawa T, Takahashi Y, Ito H. Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter? Ann Surg Oncol 2017;24:3368-75. [PMID: 28799027 DOI: 10.1245/s10434-017-6044-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
62 Zheng Y, Yang P, Chen J, Yu K, Ye Y, Zhang L, Hou X, Wang D. Endoscopic excision as a viable alternative to major resection for early duodenal cancers: A population-based cohort study. Int J Surg 2022;101:106644. [PMID: 35500880 DOI: 10.1016/j.ijsu.2022.106644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Solaini L, Jamieson NB, Metcalfe M, Abu Hilal M, Soonawalla Z, Davidson BR, McKay C, Kocher HM; UK Duodenal Cancer Study Group. Outcome after surgical resection for duodenal adenocarcinoma in the UK. Br J Surg. 2015;102:676-681. [PMID: 25776995 DOI: 10.1002/bjs.9791] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
64 Bourgouin S, Ewald J, Mancini J, Moutardier V, Delpero JR, Le Treut YP. Predictors of Survival in Ampullary, Bile Duct and Duodenal Cancers Following Pancreaticoduodenectomy: a 10-Year Multicentre Analysis. J Gastrointest Surg 2015;19:1247-55. [PMID: 25947547 DOI: 10.1007/s11605-015-2833-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
65 Ecker BL, McMillan MT, Datta J, Lee MK, Karakousis GC, Vollmer CM Jr, Drebin JA, Fraker DL, Roses RE. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database. Cancer. 2017;123:967-976. [PMID: 28263387 DOI: 10.1002/cncr.30439] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
66 Cumberledge JD, Anaka I, Kupec JT. Rare case of small intestine bleeding. BMJ Case Rep 2019;12:e227184. [PMID: 30700455 DOI: 10.1136/bcr-2018-227184] [Reference Citation Analysis]
67 Abe N, Suzuki Y, Masaki T, Mori T, Sugiyama M. Surgical management of superficial non-ampullary duodenal tumors. Dig Endosc. 2014;26 Suppl 2:57-63. [PMID: 24750150 DOI: 10.1111/den.12272] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
68 Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT, Fraker DL, Drebin JA, Karakousis GC, Roses RE. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis. Cancer. 2016;122:693-701. [PMID: 26717303 DOI: 10.1002/cncr.29840] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
69 Ohata K, Nonaka K, Sakai E, Minato Y, Satodate H, Watanabe K, Matsuhashi N. Novel technique of endoscopic full-thickness resection for superficial nonampullary duodenal neoplasms to avoid intraperitoneal tumor dissemination. Endosc Int Open 2016;4:E784-7. [PMID: 27556096 DOI: 10.1055/s-0042-107666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
70 Ye X, Zhang G, Chen H, Li Y. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. PLoS One 2018;13:e0200204. [PMID: 30096150 DOI: 10.1371/journal.pone.0200204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
71 Kim MJ, Choi SB, Han HJ, Park PJ, Kim WB, Song TJ, Suh SO, Choi SY. Clinicopathological analysis and survival outcome of duodenal adenocarcinoma. Kaohsiung J Med Sci. 2014;30:254-259. [PMID: 24751389 DOI: 10.1016/j.kjms.2013.12.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
72 Arima K, Okabe H, Hashimoto D, Chikamoto A, Nitta H, Higashi T, Kaida T, Yamamura K, Kitano Y, Komohara Y, Yamashita YI, Beppu T, Takeya M, Baba H. Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors. Int J Clin Oncol. 2017;22:734-739. [PMID: 28285371 DOI: 10.1007/s10147-017-1111-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
73 Fu T, Sharmab A, Xie F, Liu Y, Li K, Wan W, Baylin SB, Wolfgang CL, Ahuja N. Methylation of MGMT Is Associated with Poor Prognosis in Patients with Stage III Duodenal Adenocarcinoma. PLoS One 2016;11:e0162929. [PMID: 27643594 DOI: 10.1371/journal.pone.0162929] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
74 Burasakarn P, Higuchi R, Nunobe S, Kanaji S, Eguchi H, Okada KI, Fujii T, Nagakawa Y, Kanetaka K, Yamashita H, Yamada S, Kuroda S, Aoyama T, Akahori T, Nakagawa K, Yamamoto M, Yamaue H, Sho M, Kodera Y; Japan Duodenal Cancer Guideline Committee. Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis. Int J Clin Oncol 2021;26:450-60. [PMID: 33386555 DOI: 10.1007/s10147-020-01840-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
75 Buanes TA. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research. World J Gastroenterol 2016; 22(48): 10502-10511 [PMID: 28082802 DOI: 10.3748/wjg.v22.i48.10502] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
76 Sunil BJ, Seshadri RA, Gouthaman S, Ranganathan R. Long-Term Outcomes and Prognostic Factors in Periampullary Carcinoma. J Gastrointest Canc 2017;48:13-9. [DOI: 10.1007/s12029-016-9863-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
77 López-Domínguez J, Busquets J, Secanella L, Peláez N, Serrano T, Fabregat J. Duodenal adenocarcinoma: Surgical results of 27 patients treated at a single center. Cir Esp (Engl Ed) 2019;97:523-30. [PMID: 31563268 DOI: 10.1016/j.ciresp.2019.06.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]